The Journal of Organic Chemistry
Page 28 of 29
1
2
3
4
5
6
REFERENCES
7
8
9
(1) (a) Frank, H.; Heinisch, G. In Pharmacologically Active Pyridazine Part1, Progress in Medicinal Chemistry; Ed. Elsevier Science B. V:
Amsterdam 1990, 271. (b) Frank, H.; Heinisch, G. In Pharmacologically Active Pyridazines Part 2, Progress in Medicinal chemistry; Ed.
Elsevier Science B. V: Amsterdam 1992, 141. (c) Basile, A. S.; Lippa, A. S.; Skolnick, P. Eur. J. Pharmacol. 2004, 500, 441-451. (d)
McIntyre C. J; Ponticello G. S; Liverton N. J; O'Keefe S. J; O'Neill E. A; Pang M.; Schwartz C. D; Claremon D. Bioorg. Med. Chem. Lett.
2002, 12, 689-692. (e) Li, C. S.; Brideau, C.; Chan, C. C.; Savoie, C.; Claveau, D.; Charleson, S.; Gordon, R.; Greig, G.; Gauthier, J. Y.;
Lau, C. K.; Riendeau, D.; Therien, M.; Wong, E.; Prasit, P. Bioorg. Med. Chem. Lett. 2003, 13, 597-600. (f) Ritchie, T. J.; Macdonald, S. J.
F.; Peace, S.; Pickett, S. D.; Luscombe, C. N. Med. Chem. Commun. 2012, 3, 1062-1069. (g) Wermuth, C. G. Med. Chem. Commun. 2011, 2,
935-941. (h) Asif, M. Curr. Med. Chem. 2012, 19, 2984-2991. (i) Asif, M.; Singh, A.; Siddiqui, A. A. Med. Chem. Res. 2012, 21, 3336-3346.
(j) Amir, M.; Somakala, K.; Ali, S. Mini Rev. Med. Chem. 2013, 13, 2082-2096.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(2) (a) Wermuth, C. G.; Bourguignon, J.J.; Hoffmann R.; Boigegrain, R; Brodin, R; Kan, J. P.; Soubrié, P. Bioorg Med Chem, Letters 1992,
2, 833-838. (b) Bourotte, M.; Pellegrini, M.; Bourguignon, J.J. Synlett 2003, 10, 1482-1484.
(3) (a) Wermuth, C. G.; Bourguignon, J.J.; Schlewer, G.; Gies, J.P.; Schoenfelder A.; Melikian A.; Bouchet, M. J.; Chantreux, D.; Molimard,
J. C.; Heaulme, M.; Chambon, J. P.; Bizière, K. J. Med. Chem. 1987, 30, 239-249. (b) Contreras, J.M.; Rival, Y.; Chayer, S.; Bourguignon,
J.J.; Wermuth, C. G. J. Med Chem 1999, 42, 730-741. (c) Rival, Y.; Hoffmann, R.; Didier, B.; Rybaltchenko, V.; Bourguignon J.J.;
Wermuth, C. G J. Med. Chem. 1999, 41, 311-317. (d) Gleave, R. J.; Beswick, P. J.; Brown, A. J.; Giblin, G. M. P.; Goldsmith, P.; Haslam, C.
P.; Mitchell, W. L.; Nicholson, N. H.; Page, L. W.; Patel, S.; Roomans, S.; Slingsby, B. P.; Swarbrick, M. E. Bioorg. Med. Chem. Lett. 2010,
20, 465-468. (e) Velentza, A. V.; Wainwright, M. S.; Zasadzki, M.; Mirzoeva, S.; Schumacher, M.; Haiech, J.; Focia, P. J.; Egli, M.;
Waterson, D. M. Bioorg. Med. Chem. Lett. 2003, 13, 3465-3470.
(4) Munoz, L.; Ranaivo, H. R.; Roy, S. M.; Hu, W.; Craft J. M.; McNamara, L. K.; Chicol, L. W.; Van Eldik, L. J.; Watterson, D. M. J.
Neuroinflamm. 2007, 4, 21.
(5) (a) Bizière, K.; Worms, P.; Kan, J. P.; Mandel, P.; Garattini, S.; Roncucci, R. Drugs Exp. Clin. Res. 1985, 11, 831-840. (b) Wermuth, C.
G.; Schlewer, G.; Bourguignon, J.J.; Maghioros, G.; Bouchet, M-J.; Moire, C.; Kan, J-P.; Worms, P.; Biziere, K. J. Med. Chem. 1989, 32,
528-537.
(6) (a) Kan, J. P.; Mouget-Goniot, C.; Worms P.; Biziere C. Biochem.Pharmacol. 1986, 35, 973-978. (b) Isel, F.; Mandel, P. Pharmacol.
Biochem. Behav. 1989, 33, 655-662.
(7) (a) Lenke, D.; Gries, J.; Kretzschmar, R. Arzneimittel –Forschung, 1981, 31, 1544-1557. (b) Araujo, D.; Caramona, M. M; Osswald, W.
Eur. J. Pharm. 1983, 90, 203-214.
(8) Lévay, G.; Gacsályi, I.; Markó, B.; Schmidt, E.; Egyed, A.; Kompagne, H.; Leveleki, C.; Miklósné Kóvacs, A.; Szénási, G.; Wellmann,
J.; Hársing, L. G.; Barkóczy J.; Simig, G.; Kótay Nagy, P. WO2004/043465 A1, 2004.
(9) (a) Boger, D. L. Chem. Rev. 1986, 86, 781-794. (b) Rickborn, B. Organic Reactions 1998, 53, 223. (c) Figeys, H. P.; Mathy, A.; Dralants,
A. Synthetic Communications 1981, 11, 655-662. (d) Boger, D. L.; Patel, M. Prog. Heterocycl. Chem. 1989, 1, 30-84. (e) Müller, K.; Sauer J.
Tetrahedron Lett. 1984, 25, 2541-2544. (f) Sauer, J. Comprehensive Heterocyclic Chemistry II, 1996, 6, 901-955.
(10) (a) Baoan Song, W. J.; Chen, H.; Bhadury, P.; Hu, D. Molecules 2009, 14, 3676-3687. (b) Estevez, I.; Ravina, E.; Sotel, E. J. Het.
Chem. 1998, 35, 1421-1427. (c) Dajka-Halasz, B.; Foldi, A. A.; Ludanyi, K.; Matyus, P. Arkivoc 2008, 3, 102-126.
(11) Sircar, I. J. Het. Chem. 1983, 20, 1473-1476.
(12) Cao, P.; Qu, J.; Burton G.; Rivero, R. A. J. Org. Chem. 2008, 73, 7204-7208
28
ACS Paragon Plus Environment